Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

It was a question Dr. Gideon Lack asked often, when giving lectures to fellow allergists and pediatricians on the topic of food allergies: How many doctors in the room had a patient allergic to ...

At the time, I shared the advice based on the recommendation of a performance coach and several sleep-deprived individuals who had given it a try. I’m happy to report science has now confirmed the ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

Qiang Tang receives funding from Google via Digital Future Initiative to support the research on this project. Moti Yung works for Google as a distinguished research scientist. Yanan Li is supported ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

As companies like Amazon and Microsoft lay off workers and embrace A.I. coding tools, computer science graduates say they’re struggling to land tech jobs. Manasi Mishra recently graduated from Purdue ...

Abstract: This study investigates the influence of personality traits on computer programming performance among computer science students. Programming proficiency is crucial for developing analytical ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...